Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 5/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Decisiveally Navigating Challenges For Enhanced Financial Health And Market Position
CVS VALUATION
CVS Health Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$65.00 |
52 Week High | US$83.25 |
52 Week Low | US$52.77 |
Beta | 0.53 |
11 Month Change | 12.11% |
3 Month Change | 5.52% |
1 Year Change | -9.73% |
33 Year Change | -23.43% |
5 Year Change | -2.34% |
Change since IPO | 9,800.66% |
Recent News & Updates
CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10Recent updates
CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15Shareholder Returns
CVS | US Healthcare | US Market | |
---|---|---|---|
7D | -1.4% | -1.0% | 1.1% |
1Y | -9.7% | 3.6% | 32.2% |
Return vs Industry: CVS underperformed the US Healthcare industry which returned 3.6% over the past year.
Return vs Market: CVS underperformed the US Market which returned 32.2% over the past year.
Price Volatility
CVS volatility | |
---|---|
CVS Average Weekly Movement | 4.1% |
Healthcare Industry Average Movement | 6.8% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 14.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CVS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CVS's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
CVS fundamental statistics | |
---|---|
Market cap | US$81.77b |
Earnings (TTM) | US$7.19b |
Revenue (TTM) | US$361.86b |
11.4x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CVS income statement (TTM) | |
---|---|
Revenue | US$361.86b |
Cost of Revenue | US$309.85b |
Gross Profit | US$52.00b |
Other Expenses | US$44.81b |
Earnings | US$7.19b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 06, 2024
Earnings per share (EPS) | 5.72 |
Gross Margin | 14.37% |
Net Profit Margin | 1.99% |
Debt/Equity Ratio | 86.5% |
How did CVS perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield45%
Payout RatioDoes CVS pay a reliable dividends?
See CVS dividend history and benchmarksCVS Health dividend dates | |
---|---|
Ex Dividend Date | Oct 21 2024 |
Dividend Pay Date | Nov 01 2024 |
Days until Ex dividend | 5 days |
Days until Dividend pay date | 16 days |
Does CVS pay a reliable dividends?
See CVS dividend history and benchmarks